# The Colitis Once Daily Asacol Study

> **NCT00708656** · PHASE3 · COMPLETED · sponsor: **Cardiff and Vale University Health Board** · enrollment: 213 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** mesalazine (Asacol®)

## Key facts

- **NCT ID:** NCT00708656
- **Lead sponsor:** Cardiff and Vale University Health Board
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2010-07
- **Final completion:** 2010-09
- **Target enrollment:** 213 (ACTUAL)
- **Last updated:** 2020-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00708656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00708656, "The Colitis Once Daily Asacol Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00708656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*